Results from long awaited Ivermectin for COVID... - CLL Support
Results from long awaited Ivermectin for COVID-19 Oxford University (PRINCIPLE) study of 8,800 COVID positive participants. It doesn't help!
You need to be a member of this community to see this post.
Read more about...
22 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Combining the Influenza and COVID-19 vaccines.
5-adapted bivalent COVID-19 vaccine given at the same visit.
The data from the trial...
COVID-19 among fit patients with CLL treated with venetoclax-based combinations
best supportive care.\\"
\\"To our knowledge, we here report the first analysis of COVID-19 in CLL...
STORM CHASER MISSES THE TARGET
placebo-controlled Phase III STORM CHASER study in people exposed to the SARS-CoV-2 virus....
USA government Approves Evusheld but UK still waiting
\\"The COVID-19 Treatment Guidelines Panel...recommends using ... (Evusheld) as SARS-CoV-2...
An unusual, potent antibody to SARS-CoV-2 variants is isolated from a recovered patient
of recovered Covid patients.
\\"Here, we report a panel of SARS-CoV-2 antibodies... from an...
Good news on vaccine efficacy for the 80%
DOES IVERMECTIN SLOW CLL
